Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9892111 | The Journal of Steroid Biochemistry and Molecular Biology | 2005 | 9 Pages |
Abstract
The hepatic metabolism of the 16-androstene steroids was investigated using isolated porcine hepatocytes. This study demonstrated that the liver is capable of producing both phase I and phase II steroid metabolites from 16-androstene steroid precursors. 16-Androstene metabolites were recovered by solid-phase extraction and identified by gas chromatography-mass spectrometry (GC-MS). When 5α-androstenone was provided as a substrate, both 3β- and 3α-androstenol were produced as well as a metabolite that showed evidence of hydroxylation. Incubations with the various 16-androstene steroids produced metabolic profiles which suggested that the major role of the liver is phase II conjugation. Sulfoconjugated 16-androstene steroids included androstadienol, 5α-androstenone, 3β-, 3α-androstenol, and possibly the hydroxylated metabolite of 5α-androstenone. It was determined that hydroxysteroid sulfotransferase (HST) is the likely candidate for the sulfoconjugation of the 16-androstene steroids within the liver. Despite the capacity of the hepatocytes to sulfoconjugate the 16-androstene steroids, the principle metabolites produced from incubations with 5α-androstenone, 3β-, and 3α-androstenol were glucuronide conjugates, accounting for approximately 68% of all phase II metabolism. These findings underline the importance of steroid conjugation and suggest that hepatic metabolism of the 16-androstene steroids may influence the levels of 5α-androstenone present in the circulation, and thus, capable of accumulating in fat.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
P.A. Sinclair, S. Hancock, W.J. Gilmore, E.J. Squires,